Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

0.9295 +0.0195 (+2.14%)
Streaming Delayed Price Updated: 2:22 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jaguar Health, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, CA / ACCESSWIRE / July 23, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ('Jaguar' or the 'Company') announced today that effective July 15, 2021, the Company granted nonstatutory stock... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
24 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 36.9% to $3.86 in pre-market trading after gaining more than 3% on Monday. SuperCom Ltd. (NASDAQ: SPCB) shares... 
Via Benzinga
News headline image
Napo EU S.p.A., Jaguar Health's Italian Subsidiary, and Dragon SPAC S.p.A. Announce Close of 8,830,000 Euro Dragon SPAC Financing
Napo EU, the identified target of Dragon SPAC, seeks to develop plant-based crofelemer to potentially treat orphan disease - short bowel syndrome (crofelemer has received orphan-drug designation from... 
From Jaguar Health, Inc.
Via AccessWire
Thinking About Buying Stock In Alibaba, Coinbase Or Jaguar Health? ↗
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why I... 
Via Benzinga
Why Jaguar Health's Stock Is Trading Lower Today ↗
Jaguar Health (NASDAQ:JAGX) shares are trading l... 
Via Benzinga
News headline image
Jaguar Health Announces Completion of Investigator-Initiated Phase 2 HALT-D Study Evaluating Mytesi (Crofelemer) for Prevention and Prophylaxis of Diarrhea in Breast Cancer Patients
Abstract of study results submitted by the third-party investigators to December 2021 San Antonio Breast Cancer Symposium SAN FRANCISCO, CA / ACCESSWIRE / July 14, 2021 / Jaguar Health, Inc.... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, August 6, 2021 and Encourages All Shareholders to Vote
Based on a preliminary review of votes cast, over 74% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene August 6, 2021 at 8:30 AM Pacific Standard Time to provide time to... 
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
31 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers TESSCO Technologies Incorporated (NASDAQ: TESS) shares rose 46% to $8.41 in pre-market trading after the company reported strong preliminary results for its first quarter... 
Via Benzinga
News headline image
JAGX Stock: The New Analyst Price Target Making Jaguar Health Jump Today ↗
Jaguar Health (JAGX) stock is jumping higher on Wednesday after an analyst initiated coverage of the shares with a positive rating. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021 ↗
Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
News headline image
Jaguar Health Set to Join Russell Microcap Index
Jaguar kicks off educational awareness contest about medicinal plants SAN FRANCISCO, CA / ACCESSWIRE / June 23, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that... 
From Jaguar Health, Inc.
Via AccessWire
Topics Derivatives
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Satsuma Pharmaceuticals (NASDAQ:STSA 
Via Benzinga
News headline image
Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, July 9, 2021 and Encourages All Shareholders to Vote
Based on a preliminary review of votes cast, over 76% have voted in favor of Proposals 2, 3, 4 & 6 Meeting scheduled to reconvene July 9, 2021 at 8:30 AM Pacific Standard Time to provide time to reach... 
From Jaguar Health, Inc.
Via AccessWire
Topics Regulatory Compliance
News headline image
24 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Medley Management Inc. (NASDAQ: MDLY) rose 144.9% to $14.30 in pre-market trading after gaining 9% on Wednesday. Medley LLC recently received NYSE notice regarding... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Enzo Biochem (NYSE:ENZ) stock increa... 
Via Benzinga
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, CA / ACCESSWIRE / June 4, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today that effective May 27, 2021, the Company granted nonstatutory stock options... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
REMINDER: Innovators with Jane King Webcast Interview with Jaguar Health CEO Lisa Conte & Dragon SPAC Founding Sponsor Josh Mailman to Take Place Thursday, June 3, 2021 at 8:30 AM Eastern
Registration link for webcast appears below SAN FRANCISCO, CA / ACCESSWIRE / June 2, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") issued a reminder today that an Innovators with... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
JAGX Stock: 2 Big Reasons Jaguar Health Is Climbing Higher Today ↗
Today, a variety of factors are taking investors in JAGX stock on a very nice ride, as the company made a couple key announcements. 
Via InvestorPlace
News headline image
Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU
Jaguar & Dragon SPAC announce initial funding of $10.8 million into Dragon SPAC Napo EU to focus initially on conditional approval for an important orphan indication, short bowel syndrome (SBS), a... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
Jaguar Health & Dragon SPAC Announce Initial Funding of US$10.8 Million into Dragon SPAC
Napo EU S.p.A., named target of Dragon SPAC, provides update on plan to pursue conditional marketing authorization for crofelemer in EU Equita Group S.p.A., a leading Italian based investment bank,... 
From Jaguar Health, Inc.
Via AccessWire
Topics Initial Public Offering
News headline image
Psychedelic Drug Stocks Index -21% In May; Now -25% YTD ↗
46 psychedelic drug stocks now trade on the various North American stock exchanges and the 11 with the largest market capitalizations make up the Pure-Play Psychedelic Drug Stocks Index. 
Via Talk Markets
News headline image
JAGX Stock: Why Jaguar Health Is Climbing Higher Today ↗
Investors in JAGX stock are having a solid week, after the company made a few key announcements that have taken this stock higher. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Gainers Owens & Minor (NYSE:OMI) shares rose 25.47% to $40.66 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 5.4... 
Via Benzinga
News headline image
Napo Pharmaceuticals, Jaguar Health’s Subsidiary, Bolsters Management Team with Appointment of Darlene Horton, M.D. as Chief Medical Officer
SAN FRANCISCO, CA / ACCESSWIRE / May 26, 2021 / Napo Pharmaceuticals Inc., the wholly-owned subsidiary of Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"), announced today the appointment... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
JAGX Stock: Why Jaguar Health Is Soaring on Monday ↗
Shares of Jaguar Health and JAGX stock are once again on the move today as investors price in the academic results submitted late last week. 
Via InvestorPlace
News headline image
Jaguar Health and Napo Pharmaceuticals Provide Key Findings from Cancer-related Diarrhea Abstracts Submitted to ASCO for June 2021 Annual Meeting
SAN FRANCISCO, CA / ACCESSWIRE / May 20, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the highlights of the abstract regarding patient outcomes associated with... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
Jaguar Animal Health (JAGX) Q1 2021 Earnings Call Transcript ↗
JAGX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Jaguar Health Announces the Launch of a New Social Media Channel Dedicated to Reaching the Growing Jaguar Health Community
Newly created Jaguar Health Community Instagram page introduces jaguar-themed contest SAN FRANCISCO, CA / ACCESSWIRE / May 19, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company"),... 
From Jaguar Health, Inc.
Via AccessWire
News headline image
Jaguar Health Provides Updates on Canalevia (Crofelemer), the First Plant-based Prescription Medicine Under Development for Chemotherapy-induced Diarrhea in Dogs and Exercise-induced Diarrhea in Dogs
Canalevia would be first and only FDA-approved plant-based medicine for dogs that suffer from diarrhea during chemotherapy Canalevia will be available by fourth quarter 2021, if conditionally approved... 
From Jaguar Health, Inc.
Via AccessWire
< Previous 1 2
...
17 18 19 20 21 22 23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.